MedPath
HSA Approval

ALPHAGAN P OPHTHALMIC SOLUTION 0.1% w/v

SIN17198P

ALPHAGAN P OPHTHALMIC SOLUTION 0.1% w/v

ALPHAGAN P OPHTHALMIC SOLUTION 0.1% w/v

March 7, 2025

ABBVIE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantABBVIE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SOLUTION, STERILE

OPHTHALMIC

Medical Information

S01EA05

Manufacturer Information

ABBVIE PTE. LTD.

Allergan Sales LLC

Active Ingredients

Brimonidine tartrate

0.1% w/v

Brimonidine

Documents

Package Inserts

Alphagan P Ophthalmic Solution 0.1% PI.pdf

Approved: March 7, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ALPHAGAN P OPHTHALMIC SOLUTION 0.1% w/v - HSA Approval | MedPath